The benefits and dangers when genetic testing companies partner with orphan drug developers
Pharmaceutical companies developing Orphan Drugs are increasingly partnering with direct-to-consumer (DTC) genetic testing firms to identify individuals with rare diseases, in a trend that is raising concerns related to privacy, ...
Sep 27, 2017
0
0